Lykos Therapeutics (formerly MAPS PBC)
Gretchen Shaub, MPP, currently serves as the Director of State Government Affairs and Advocacy at Lykos Therapeutics, having joined the company in November 2023. Prior to this role, Gretchen held the position of Stakeholder Relationship Manager at COMPASS Pathways from June 2021 to November 2023 and worked as a Senior Business Analyst at DaVita Kidney Care between December 2019 and June 2021. Previous experience includes roles as Program Manager at Accarent Health, Medical Underwriter at Tethys Health Ventures, and Policy Analyst at the Baltimore City Health Department. Gretchen began their career with a focus on policy and research as a Research Assistant at the Maryland Institute for Policy Analysis and Research and has international experience from service in the Peace Corps as a Volunteer in the Republic of Panama. Educational qualifications include a Master’s Degree in Public Policy from the University of Maryland Baltimore County and a Bachelor of Arts in Psychology and Business Administration from New York University.
Lykos Therapeutics (formerly MAPS PBC)
At Lykos Therapeutics, our mission is to transform the way mental health is treated. We aspire to challenge the status quo through the development of novel therapies and therapeutic approaches to treat mental health conditions. With 30+ years of experience researching psychedelic-assisted therapies, we remain focused on following rigorous science from which we can develop and commercialize novel treatment options. Founded in 2014 by the non-profit Multidisciplinary Association for Psychedelic Studies (“MAPS”), we are a for-profit public benefit corporation (“PBC”). As a PBC, we consider the impact of our decisions on society just as we think about financial implications. Everything we do is looked at through a public benefit lens. To learn more, visit us at www.lykospbc.com.